+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Crixivan"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Crixivan (indinavir sulfate) is an antiviral drug used to treat HIV infection and AIDS. It belongs to a class of drugs known as protease inhibitors, which work by blocking the action of the HIV protease enzyme, an enzyme essential for the replication of the virus. Crixivan is usually used in combination with other antiretroviral drugs to maximize its effectiveness. It is also used to prevent HIV infection in people who have been exposed to the virus. Crixivan is a widely used drug in the infectious diseases market. It is prescribed to HIV-positive patients to help slow the progression of the virus and reduce the risk of developing AIDS. It is also used to prevent HIV infection in people who have been exposed to the virus. The companies in the Crixivan market include Merck & Co., Inc., Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more